139 related articles for article (PubMed ID: 15637961)
21. Prostate cancer chemoprevention: what is the role of oncology nurses?
Leahy Y
Can Oncol Nurs J; 2010; 20(1):52-5. PubMed ID: 20369646
[No Abstract] [Full Text] [Related]
22. Managing drug infusion reactions: focus on cetuximab monoclonal antibody therapy.
Wilkes G
Clin J Oncol Nurs; 2008 Jun; 12(3):530-2. PubMed ID: 18515254
[No Abstract] [Full Text] [Related]
23. Rapid suppression of plasma testosterone levels and tumor growth in the dunning rat model treated with degarelix, a new gonadotropin-releasing hormone antagonist.
Princivalle M; Broqua P; White R; Meyer J; Mayer G; Elliott L; Bjarnason K; Haigh R; Yea C
J Pharmacol Exp Ther; 2007 Mar; 320(3):1113-8. PubMed ID: 17179469
[TBL] [Abstract][Full Text] [Related]
24. Toremifene citrate (Fareston).
Gerken P
Clin J Oncol Nurs; 2004 Oct; 8(5):529-30. PubMed ID: 15565747
[No Abstract] [Full Text] [Related]
25. [Pharmacology. The proper use of drugs. 10/12. The preparation and administration of antineoplastic agents and adjuvants].
Valnet-Rabier MB; Limat S; Woronoff-Lemsi MC; Belon JP
Soins; 2000 Mar; (643):51-2. PubMed ID: 11075232
[No Abstract] [Full Text] [Related]
26. Prescription drugs uses and effects. Corticosteroids.
Jordan S; Griffiths H
Nurs Stand; 2004 Mar 17-23; 18(27):2p.. PubMed ID: 15061025
[No Abstract] [Full Text] [Related]
27. Gonadotropin-releasing hormone: an update review of the antagonists versus agonists.
Van Poppel H; Klotz L
Int J Urol; 2012 Jul; 19(7):594-601. PubMed ID: 22416801
[TBL] [Abstract][Full Text] [Related]
28. Venous thromboembolism in patients with cancer. Part II. Current treatment strategies.
Viale PH; Schwartz RN
Clin J Oncol Nurs; 2004 Oct; 8(5):465-9. PubMed ID: 15515280
[TBL] [Abstract][Full Text] [Related]
29. Docetaxel-related side effects and their management.
Baker J; Ajani J; Scotté F; Winther D; Martin M; Aapro MS; von Minckwitz G
Eur J Oncol Nurs; 2008 Jul; 12(3):253-68. PubMed ID: 18501674
[TBL] [Abstract][Full Text] [Related]
30. Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma.
Malizzia LJ; Hsu A
Clin J Oncol Nurs; 2008 Aug; 12(4):639-46. PubMed ID: 18676330
[TBL] [Abstract][Full Text] [Related]
31. A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents.
Bedell CH
Clin J Oncol Nurs; 2003; 7(6 Suppl):5-9. PubMed ID: 14705494
[TBL] [Abstract][Full Text] [Related]
32. Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomy.
Beer TM; Garzotto M; Eilers KM; Lemmon D; Wersinger EM
Urology; 2004 Feb; 63(2):342-7. PubMed ID: 14972486
[TBL] [Abstract][Full Text] [Related]
33. Management of advanced prostate cancer: gonadotropin-releasing hormone blockers might improve prognosis.
Heidenreich A
Eur Urol; 2008 Oct; 54(4):726-7. PubMed ID: 18524468
[No Abstract] [Full Text] [Related]
34. The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.
Yannucci J; Manola J; Garnick MB; Bhat G; Bubley GJ
J Urol; 2006 Aug; 176(2):520-5. PubMed ID: 16813881
[TBL] [Abstract][Full Text] [Related]
35. Management of novel therapeutics' side effects: a nurse-centric model.
Davies MJ
ONS Connect; 2007; 22(8 Suppl):25-6. PubMed ID: 17824551
[No Abstract] [Full Text] [Related]
36. Five years' clinical use of GnRH antagonists: evaluation of safety and allergic potential.
Engel JB; Schultze-Mosgau A; Diedrich K
Reprod Biomed Online; 2005 Jun; 10 Suppl 3():61-5. PubMed ID: 23577417
[TBL] [Abstract][Full Text] [Related]
37. Roles of the urologist and nurse from the perspective of patients with prostate cancer receiving luteinizing hormone-releasing hormone analogue therapy.
Lebret T; Bouregba A
BJU Int; 2008 Nov; 102(10):1419-24. PubMed ID: 18549431
[TBL] [Abstract][Full Text] [Related]
38. Communicating the safety essentials of oral anticoagulant therapy.
Lamarche K; Heale R
Home Healthc Nurse; 2007; 25(7):448-56; quiz 457-8. PubMed ID: 17667004
[No Abstract] [Full Text] [Related]
39. Cardiovascular toxicity associated with cancer treatment.
Viale PH; Yamamoto DS
Clin J Oncol Nurs; 2008 Aug; 12(4):627-38. PubMed ID: 18676329
[TBL] [Abstract][Full Text] [Related]
40. Metoclopramide.
Nurs Times; 2005 Mar 22-28; 101(12):37. PubMed ID: 15822709
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
